Distinct and Common Fibrotic Pathways in Metabolic Dysfunction-Associated Steatohepatitis Versus MetALD

Nov 16 2024
Convention Center: Room 28 E
12:45 PM - 1:30 PM
Ticketed Event

World Class Speakers

Tatiana Kisseleva, MD, PhD
Discussion Leader

Tatiana Kisseleva, MD, PhD

University of California, San Diego
WM
Discussion Leader

Wajahat Mehal, MD, FAASLD

Yale University

Description

Speakers present the common and distinct pathways involved in hepatic stellate cell activation and fibrogenesis in metabolic dysfunction-associated steatohepatitis (MASH) and MetALD in relation to disease-specific therapeutic approaches. 

Journey Maps

Objectives

  • Explain what is known about the common and distinct pathways contributing to fibrogenesis in MASH versus MetALD.
  • Describe how knowledge about the common and distinct pathways contributing to fibrogenesis in MASH and MetALD may aid in the design of disease-specific therapeutic interventions.